UK probing Novo’s Ozempic’s drug over suicidal, self-harming thoughts
Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients reported suicidal or self-harming thoughts, two weeks after similar action by the European Union. The Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement to Reuters late on Tuesday it […]
Continue Reading